A gene expression signature (including LGALS12, ALOX15, CLC, IL1RL1, CD24, and EMR4P) was associated with shorter time to the first exacerbation after ICS withdrawal and demonstrated a higher predictive value than sputum eosinophil levels among COPD patients. This evidence concerns the gene LGALS12 and chronic obstructive pulmonary disease.